![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Hikma Pharmaceuticals Plc | LSE:HIK | London | Ordinary Share | GB00B0LCW083 | ORD SHS 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
7.00 | 0.37% | 1,882.00 | 1,881.00 | 1,883.00 | 1,897.00 | 1,877.00 | 1,897.00 | 65,299 | 12:08:43 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 2.88B | 192M | 0.8653 | 21.74 | 4.17B |
Date | Subject | Author | Discuss |
---|---|---|---|
26/4/2024 10:00 | Yes, if you believe that they can grow earnings at mid to high single digit percentages, the multiple should be at least mid teens here. Think its one to just be patient on. Nice to see a little bit of life this morning | ![]() adamb1978 | |
25/4/2024 13:24 | Nothing exceptional in the tu - just confirms that it is relatively cheap as Adam notes. Odd initial negative reaction this morning, quickly reversed and those getting in early now have a quick gain. I would think that it should share in a general recovery of the sector if interest rates moderate. | ![]() boadicea | |
25/4/2024 07:48 | Decent trading statement this morning? PE of only c.11x for this year - feels like good risk/reward bet at these levels IMO | ![]() adamb1978 | |
22/3/2024 20:32 | This is the APH that has nearly halved in 6 months.Trading Hikma is proving profitable and still it's performed far better than your ongoing pumping of APH.I hope people research before buying anything that people are pumping on bulletin boards.. | ![]() hopeful holder | |
21/3/2024 13:00 | An XD related move of ~37p should not have resulted in a ~100p drop in the sp! I wonder whether it helped to trigger some stop-losses? - Ha-ha. | ![]() boadicea | |
21/3/2024 08:56 | Money moving to APH [LSE] , excellent profitable healthcare company | blackhorse23 | |
22/2/2024 07:13 | So a beat on all of those, but quite a lot of exceptional which need looking at - $129m of which opioid related. Agree div increase much more than expected. | ![]() 18bt | |
22/2/2024 07:06 | Dividend hike is chunky | ![]() robertball | |
22/2/2024 07:02 | Latest estimates for 2023: Rev $2850m PTP 522.6m EPS 211.5c Div 48.1c | ![]() 18bt | |
13/1/2024 21:31 | So far, HIK has proven to be better even over this short period. | ![]() hopeful holder | |
28/12/2023 10:16 | Any researching APH will probably come up with an opinion of, they are not the best by a long way. But... I'm always open to knowing why you think they are better than Hikma. | ![]() hopeful holder | |
03/11/2023 00:11 | looks like best value healthcare stock is APH | blackhorse23 | |
02/11/2023 18:31 | The Jordanian mafia | ![]() dartboard1 | |
02/11/2023 17:22 | The market do not trust what they say. Clearly a dodgy company | ![]() wolfhh | |
02/11/2023 08:06 | Decent enough trading statement. PE is only around 12x, which feels very very cheap to me | ![]() adamb1978 | |
02/11/2023 07:44 | One day the EGP will go up... but not this year.... | ![]() dartboard1 | |
02/11/2023 07:10 | Kind of ok | ![]() robertball | |
30/8/2023 08:57 | Not caught by Us drug announcement yesterday re price controls... | ![]() robertball | |
11/8/2023 16:03 | Susan did very well. | ![]() chc15 | |
09/8/2023 08:46 | He already works there... | ![]() robertball | |
09/8/2023 08:03 | New Injectables big shot announced. | ![]() boadicea | |
24/7/2023 08:08 | How much of a bonus boost will a weakening £ have? | ![]() robertball | |
20/7/2023 09:29 | Oh yeah... says the warehouse had injectables with similar compounds... well that's a stroke of luck | ![]() dartboard1 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions